| EYEPOINT PHARMACEUTICALS |
| USA |
| Gesundheit |
| US30233G2093 / A2QJRU |
| PV3B (Frankfurt) / EYPT (NASDAQ) |
| FRA:PV3B, ETR:PV3B, PV3B:GR, NASDAQ:EYPT |
| - |
| https://eyepointpharma.co.. |
|
EyePoint Pharmaceuticals Inc. is a specialty bioph..
>Volltext.. |
| 1205.97 Mio. EUR |
| 1051.81 Mio. EUR |
| 36.15 Mio. EUR |
| -184.65 Mio. EUR |
| -175.69 Mio. EUR |
| -2.55 EUR |
| 19.86 Mio. EUR |
| 63.68 Mio. EUR |
| -180.09 Mio. EUR |
| 6.78 |
| -12.12% |
| -88.5% |
| - |
| - |
| - |
| EYEPOINT |
| 22.12.25 |